Omnicell Inc
OMCL
Company Profile
Business description
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
Contact
4220 North Freeway
Fort Worth
Santa ClaraCA76137
USAT: +1 877 415-9990
Sector
Healthcare
Stock type
Defensive
Industry
Health Information Services
Fiscal Year End
31 December 2026
Employees
3,600
Stocks News & Analysis
stocks
More US tech stocks look cheap as the market rotates
Meanwhile, value-leaning areas of the market, including industrials and energy stocks, are moving out of undervalued territory.
stocks
Earnings Losers: GYG, DMP & LLC slump on souring market sentiment
The results that fell short of market expectations.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,396.20 | 46.20 | 0.49% |
| CAC 40 | 8,580.75 | 40.18 | -0.47% |
| DAX 40 | 25,284.26 | 4.76 | -0.02% |
| Dow JONES (US) | 48,977.92 | 521.28 | -1.05% |
| FTSE 100 | 10,910.55 | 63.85 | 0.59% |
| HKSE | 26,630.54 | 249.52 | 0.95% |
| NASDAQ | 22,668.21 | 210.17 | -0.92% |
| Nikkei 225 | 57,391.94 | 1,458.33 | -2.48% |
| NZX 50 Index | 13,584.41 | 138.56 | -1.01% |
| S&P 500 | 6,878.88 | 29.98 | -0.43% |
| S&P/ASX 200 | 9,164.00 | 44.30 | 0.49% |
| SSE Composite Index | 4,162.88 | 16.25 | 0.39% |